Effects of oxygen deprivation on cardiac redox systems.
Division of Pharmacology and Toxicology, College of Pharmacy, University of Texas, Austin 78712-1074.
J P
JP
Kehrer
T
T
Paraidathathu
L G
LG
Lund
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000378:metabolism; D003958:Diamide / Q000494:pharmacology; D004734:Energy Metabolism / Q000502:physiology; D005978:Glutathione / Q000378:metabolism; D000860:Hypoxia / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D008929:Mitochondria, Heart / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction; D010725:Phosphocreatine / Q000378:metabolism; D011725:Pyridines / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D013050:Spectrometry, Fluorescence
D000227:Adenine Nucleotides; D011725:Pyridines; D017382:Reactive Oxygen Species; D010725:Phosphocreatine; D009243:NAD; D003958:Diamide; D009249:NADP; D003404:Creatinine; D005978:Glutathione